ORAGENICS INC (OGEN)
2025-06-30 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Income (loss) from continuing operations before income taxes, noncontrolling interest | - | -2,462,870 | -2,305,090 | |
| Research and development | 449,679 | 879,041 | 906,779 | |
| General and administrative | 1,264,523 | 1,558,239 | 1,399,221 | |
| Total operating expenses | 1,714,202 | 2,437,280 | 2,306,000 | |
| Loss from operations | -1,714,202 | -2,437,280 | -2,306,000 | |
| Interest income | 16,793 | 9,466 | 6,405 | |
| Interest expense | 572,310 | 9,971 | 1,803 | |
| Foreign currency exchange net | -2,316 | -25,085 | -3,692 | |
| Total other (expense) income, net | -557,833 | -25,590 | 910 | |
| Net loss | -2,272,035 | -2,462,870 | -2,305,090 | |
| Basic net loss per share | -3.1 | -0.38 | -0.51 | |
| Diluted net loss per share | -3.1 | -0.38 | -0.51 | |
| Weight-average shares outstanding, basic | 731,817 | 6,528,064 | 4,529,045 | |
| Weight-average shares outstanding, diluted | 731,817 | 6,528,064 | 4,529,045 | |